参考文献：1.Opdivo Prescribing Information. Opdivo U.S. Product Information. Last updated: March 2024. Princeton, N.J.: Bristol Myers Squibb Company.2.American Cancer Society. About Bladder Cancer. Available at https://www.cancer.org/cancer/types/bladder-cancer/about.html. Accessed February 06, 2024.3.ClinicalTrials.gov: NCT03036098. Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer (CheckMate901). Available at https://clinicaltrials.gov/study/NCT03036098&rank=1. Accessed February 06, 2024.4.van der Heijden MS, Sonpavde G, Powles T, et al. Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma. N Engl J Medicine. 2023; 389:1778-1789. doi:10.1056/NEJMoa23098635.SEER. Cancer Stat Facts: Bladder Cancer. Available at https://seer.cancer.gov/statfacts/html/urinb.html. Accessed February 06, 2024.6.Ameri
………………………………
